On this episode of Health O’Clock, the focus is on the Indian drug regulator CDSCO’s approval of the blockbuster drug Ozempic. It is cleared for treating type 2 diabetes and reducing risks of serious heart and kidney problems, but explicitly not for weight loss. The program details how Ozempic, containing the molecule semaglutide, differs from similar drugs like Wegovy and Mounjaro. Dr. Rajesh Rajput explains the physician’s role, stating, "It is duty of the doctor actually to find out who is the right patient for which molecule and even within the same molecule which name or which brand." The show also covers the mysterious deaths of 14 children in Nagpur and Chhindwara in 30 days. The cause is being investigated as a possible Acute Encephalitis Syndrome (AES), with teams from the National Institute of Virology and National Center for Disease Control probing the outbreak. #healthoclock #indiatoday #ozempic #itwebvideos #ozempicindia #diabetes #weightloss #semaglutide #healthnews #cdsco #acuteencephalitissyndrome #aes #mysterydisease #childdeaths #nagpur #chhindwara #publichealthalert
Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you’ll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India’s leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.
Stay tuned for latest updates and in-depth analysis of news from India and around the world!
WhatsApp Channel: https://whatsapp.com/channel/0029Va2AnW3JENxxg7OuJv00
Download App: https://indiatoday.link/wHaj
Follow us: Official website: https://www.indiatoday.in/
Twitter: https://twitter.com/IndiaToday
Facebook: https://www.facebook.com/IndiaToday
